Vaginal misoprostol versus concentrated oxytocin and vaginal PGE 2 for second-trimester labor induction

Obstetrics and Gynecology

Volumn 104, Issue 1, 2004, Pages 138-145

  Ramsey, Patrick S ^a   Savage, Karen ^a   Lincoln, Tina ^a   Owen, John ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE PLUS DIPHENOXYLATE; METOCLOPRAMIDE; MISOPROSTOL; OXYTOCIN; PARACETAMOL; PROMETHAZINE; PROSTAGLANDIN E2; SODIUM CHLORIDE; ABORTIVE AGENT; OXYTOCIC AGENT;

ADULT; ARTICLE; CHORIOAMNIONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; FEMALE; FEVER; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; NAUSEA; POSTPARTUM HEMORRHAGE; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETAINED PLACENTA; SECOND TRIMESTER PREGNANCY; TREATMENT INDICATION; UNITED STATES; UTERINE CERVIX RIPENING; VOMITING; BLEEDING; COMPARATIVE STUDY; INTRAVAGINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PREGNANCY; PUERPERAL DISORDER; SUPPOSITORY; TIME;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADMINISTRATION, INTRAVAGINAL; ADULT; CHORIOAMNIONITIS; DINOPROSTONE; FEMALE; HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; OXYTOCIN; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PUERPERAL DISORDERS; SUPPOSITORIES; TIME FACTORS;

EID: 3242674279     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000128947.31887.94     Document Type: Article

References (28)

1. Ramsey PS, Owen J. Midtrimester cervical ripening and labor induction [review]. Clin Obstet Gynecol 2000;43: 495-512.
2. Rosenfield A. The difficult issue of second-trimester abortion. N Engl J Med 1994;31:324-5.
3. 2 vaginal suppositories for second-trimester pregnancy termination. Obstet Gynecol 1996;88:110-3.
4. Hogg BB, Owen J. Laminaria versus extra-amniotic saline infusion for cervical ripening in second-trimester labor inductions. Am J Obstet Gynecol 2001;184:1145-8.
5. 1 analog, for prelabour ripening of the unfavorable uterine cervix. Fetal Matern Med Rev 1996;217-27.
6. Wing DA, Rahall A, Jones MM, Goodwin TM, Paul RH. Misoprostol: an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol 1995;172:1811-6.
7. Sanchez-Ramos L, Kaunitz AM, Wears RL, Delke I, Gaudier FL. Misoprostol for cervical ripening and labor induction: a meta-analysis. Obstet Gynecol 1997;89: 633-42.
8. 2 for termination of second-trimester pregnancy. N Engl J Med 1994;331:290-3.
9. Jain JK, Mishell DR. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol 1996;175:173-7.
10. Herabutya Y, O-Prasertsawat P. Second trimester abortion using intravaginal misoprostol. Int J Gynecol Obstet 1998;60:161-5.
11. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 2002; 186: 470-4.
12. 2 for second trimester pregnancy termination. J Matern Fetal Med 1999;8: 48-50.
13. Scheepers HC, van Erp EJ, van den Bergh AS. Use of misoprostol in first and second trimester abortion: a review. Obstet Gynecol Surv 1999;54:592-600.
14. Yapar EG, Senoz S, Urkutur M, Batioglu S, Gokmen O. Second trimester pregnancy termination including fetal death: comparison of five different methods. Eur J Obstet Gynecol 1996;69:97-102.
15. Ramin KD, Ogburn PL, Danilenko DR, Ramsey PS. High-dose oral misoprostol for mid-trimester pregnancy interruption. Gynecol Obstet Invest 2002;54:176-9.
16. Nuutila M, Toivonen J, Ylikorkala O, Halmesmaki E. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion. Obstet Gynecol 1997;90:896-900.
17. Ho PC, Chan YF, Lau W. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomized comparative trial. Contraception 1996;53:281-3.
18. el-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 1995;10:475-8.
19. Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF, Tessier F, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 2002;187: 853-7.
20. Wong KS, Ngai CS, Yeo EL, Tang LC, Ho PC. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 2000;15:709-12.
21. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52: 591-611.
22. Chong YS, Chua S, Arulkumaran S. Severe hyperthermia following oral misoprostol in the immediate postpartum period. Obstet Gynecol 1997;90:703-4.
23. Hofmeyr GJ, Nikodem VC, de Jager M, Drakely A. Side-effects of oral misoprostol in the third stage of labour: a randomised placebo-controlled trial. S Afr Med J 2001;91: 432-5.
24. New U.S. Food and Drug Administration labeling on Cytotec (misoprostol) use in pregnancy. ACOG Committee Opinion No. 283. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003;101:1049-50.
25. American College of Obstetricians and Gynecologists. Induction of labor with misoprostol. ACOG Committee Opinion 228. Washington, DC: ACOG; 1999.
26. American College of Obstetricians and Gynecologists. Response to Searle's drug warning on misoprostol. Committee Opinion 248. Washington, DC: AGOG; 2000.
27. Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z. Misoprostol for induction of labour: a systematic review [review]. Br J Obstet Gynaecol 1999;106:798-803.
28. Goldberg AB, Greenberg MB, Darney PD. Drug therapy: misoprostol and pregnancy [review]. N Engl J Med 2001;344:38-47.